Inventor

Tarlochan S. Nijjar

Inventor

Orinda, CA, US

Overview

2013–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 28 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes28%

C07KPeptides28%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%

G01NInvestigating or analysing materials by determining their chemical or physical properties18%

C12NMicroorganisms or enzymes1%

C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms1%

Y10TTechnical subjects covered by former us classification1%

PatentTitleYear

11,028,158Anti-transthyretin antibodies2021 10,961,302Antibodies recognizing tau2021 10,906,967Anti-transthyretin antibodies2021 10,875,909Humanized antibodies that recognize alpha-synuclein2020 10,875,910Antibodies recognizing alpha-synuclein2020 10,723,792Humanized antibodies that recognize alpha-synuclein2020 10,669,330Anti-transthyretin antibodies2020 10,669,331Antibodies recognizing a-synuclein2020 10,633,433Anti-transthyretin antibodies2020 10,597,441Humanized antibodies that recognize alpha-synuclein2020 10,494,426Anti-transthyretin antibodies2019 10,464,999Anti-transthyretin antibodies2019 10,450,369Humanized antibodies that recognize alpha-synuclein2019 10,442,855Antibodies recognizing medin2019 10,301,382Antibodies recognizing alpha-synuclein2019 10,118,960Humanized antibodies that recognize alpha-synuclein2018 10,081,674Antibodies recognizing a-synuclein2018 9,951,131Antibodies that recognize IAPP2018 9,884,906'Humanized antibodies that recognize alpha-synuclein'2018 9,879,080'Anti-transthyretin antibodies'2018 9,670,273'Humanized antibodies that recognize alpha-synuclein'2017 9,605,056'Antibodies recognizing alpha-synuclein'2017 9,556,259'Humanized antibodies that recognize alpha-synuclein'2017 9,234,031'Humanized antibodies that recognize alpha-synuclein'2016 9,217,030'Humanized antibodies that recognize alpha-synuclein'2015 8,790,644'Humanized antibodies that recognize alpha-synuclein'2014 8,741,298'APOE immunotherapy'2014 8,609,820'Humanized antibodies that recognize alpha-synuclein'2013

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2013–2017Patents assigned to NEOTOPE BIOSCIENCES LTD (4)· patent assignee history

2013–2021Based in Orinda, CA, US· patent location history

2014Patents assigned to BARBOUR ROBIN (1)· patent assignee history

2014Patents assigned to NIJJAR TARLOCHAN S (1)· patent assignee history

2015–2021Patents assigned to PROTHENA BIOSCIENCES LTD (25)· patent assignee history

2018–2021Patents assigned to UNIV HEALTH NETWORK (7)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
PROTHENA BIOSCIENCES LTD	25	2015–2021
UNIV HEALTH NETWORK	7	2018–2021
NEOTOPE BIOSCIENCES LTD	4	2013–2017
BARBOUR ROBIN	1	2014
NIJJAR TARLOCHAN Sself	1	2014

Locations

Location	Patents	Span
Orinda, California, US	28	2013–2021